Magrolimab, CAS 2169232-81-7

Product Description: Magrolimab (Hu5F9-G4) is a first-in-class humanized anti-CD47 IgG4 antibody with an anti-tumor activity[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Caner Saygin, et al. Current and emerging strategies for management of myelodysplastic syndromes. Blood Rev. 2021 Jul;48:100791.

CAS Number: 2169232-81-7

Molecular Weight: N/A

Compound Purity: 99

Research Area: Cancer

Solubility: H2O

Target: Others

• Artikelnummer: MEXHY-P99029-10
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99029-10
• Green Labware: Nein
• Verpackungseinheit: 10 mg
• Mengeneinheit: STK